The GALAD score encompasses gender, age, AFP-L3 (an isoform of AFP more specific for neoplasia), AFP, and DCP and it seems to have a high prognostic accuracy in the early detection of HCC in NASH patients (area under receiver operating characteristic curve, AUROC: 0.96). This evidence concerns the gene ACE and neoplasm.